Drug Profile
Squaric acid dibutyl ester - Squarex
Alternative Names: Quadratic-acid-dibutylester; SADBE; Squaric-Acid-Dibutyl-Ester-solution; Squaric-Acid-solution; SQX 770Latest Information Update: 07 Dec 2022
Price :
$50
*
At a glance
- Originator Squarex
- Class Antivirals; Esters; Immunotherapies; Small molecules
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Herpes labialis; Herpes simplex virus infections
Most Recent Events
- 07 Dec 2022 No development reported - Phase-II for Herpes labialis (Prevention, Recurrent) in USA (Topical) prior to December 2022 (NCT03521479)
- 14 Jun 2022 The University of Texas Health Science Center plans to initiate early phase I trial in Alopecia Areata (In adolescents) in June 2022 (Topical) (NCT05414266)
- 28 Apr 2020 No recent reports of development identified for phase-I development in Herpes-simplex-virus-infections in USA (Topical, Liquid)